Biofrontera (BFRI) Net Cash Flow (2020 - 2025)
Biofrontera has reported Net Cash Flow over the past 6 years, most recently at $2.9 million for Q4 2025.
- For Q4 2025, Net Cash Flow fell 3.17% year-over-year to $2.9 million; the TTM value through Dec 2025 reached -$8.1 million, down 276.42%, while the annual FY2025 figure was $448000.0, 90.18% down from the prior year.
- Net Cash Flow for Q4 2025 was $2.9 million at Biofrontera, up from -$3.8 million in the prior quarter.
- Over five years, Net Cash Flow peaked at $22.8 million in Q4 2021 and troughed at -$10.4 million in Q4 2022.
- A 5-year average of -$1.0 million and a median of -$1.8 million in 2023 define the central range for Net Cash Flow.
- Biggest five-year swings in Net Cash Flow: soared 526.51% in 2021 and later crashed 10894.68% in 2023.
- Year by year, Net Cash Flow stood at $22.8 million in 2021, then plummeted by 145.37% to -$10.4 million in 2022, then soared by 79.88% to -$2.1 million in 2023, then surged by 245.49% to $3.0 million in 2024, then decreased by 3.17% to $2.9 million in 2025.
- Business Quant data shows Net Cash Flow for BFRI at $2.9 million in Q4 2025, -$3.8 million in Q3 2025, and -$3.1 million in Q2 2025.